scorecardresearch
Add as a preferred source on Google
Sunday, November 9, 2025
TopicAstraZeneca

Topic: AstraZeneca

AstraZeneca CEO says Oxford vaccine on track for year-end, dismisses reports of delays

Concerns about AstraZeneca’s timeline arose this week with UK saying only 4 million doses of the Oxford-Astra shot would be available by the end of the year.

AstraZeneca-Oxford vaccine is still the global front-runner despite delays

An initial interruption in AstraZeneca's vaccine trial in UK may have created a break in timeline, but has had little impact on the overall trial, putting it ahead of competitors.

AstraZeneca-Oxford Covid vaccine produces strong immune response in older adults

The Astra-Oxford vaccine candidate is one of several front-runners in the race for protection against the virus.

AstraZeneca trial volunteer in Brazil who died had been given placebo, not Covid vaccine

The trial will continue, as suggested by an international committee assessing its safety, Brazil’s health authority Anvisa said.

AstraZeneca’s Covid antibody drug heads into advanced trials

AstraZeneca drug will be assessed for ability to avoid infections for as much as a year in some people & as a pre-emptive medicine once patients are exposed to the virus in others.

Can inhaled vaccines provide better protection against coronavirus? Scientists look for answer

Covid-19 vaccines under development are injectable. Scientists are hoping for better immune responses with inhaled ones that directly target the nose & mouth.

AstraZeneca resumes Covid-19 vaccine trial in Japan, US still on hold

The phase 1 and 2 trials resumed after the Japanese regulator gave the go-ahead. Trials in the UK, Brazil, South Africa and India had already restarted in recent weeks.

Serum Institute will deliver 10 crore more doses of Covid vaccine to India, other countries

Pune-based Serum Institute of India has already committed to supplying 10 crore doses of the vaccine at a price of about Rs 225 per dose.

Chinese vaccine maker to offer shots first to countries running phase 3 trials

Sinovac, one of three Chinese vaccines in the last stages of testing, is expecting interim data as soon as November from its Phase 3 trial of almost 10,000 people in Brazil.

AstraZeneca denies vaccine trial volunteer had rare nerve ailment

AstraZeneca denied a CNN report which cited documents indicating that the diagnosis of the participant was confirmed as transverse myelitis.

On Camera

Moon madness has taken over modern dating. A waning crescent is the best time to ghost

Alongside buying into the grift that is dating apps, the girlies are also installing astrology apps like Astrotalk to investigate the same tired mystery—will he ever text back?

Africa’s blue economy is booming. What it can learn from Asia

Aquaculture is the fastest growing food sector in Africa, offering significant returns on investment for all involved and achieving the continent’s goals for food security, dignified livelihoods and economic growth.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.